Remove Ablation Remove Arrhythmia Remove Risk Factors
article thumbnail

Biosense Webster Study Supports Low and Zero Fluoroscopy Workflow as Safe, Effective Alternative to Conventional Catheter Ablation

DAIC

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , revealed findings from a company-funded study of real-world data. Biosense Webster's zero fluoroscopy workflow is the first and only such workflow available in a radiofrequency (RF) cardiac ablation device.

Ablation 105
article thumbnail

Risk factors of late arrhythmia recurrences during 12 months after catheter ablation of atrial fibrillation: Insight into atrial cardiomyopathy

HeartRhythm

A gradual increase in arrhythmia recurrences during 12 months after catheter ablation (CA) of atrial fibrillation (AF) is still reported.1 A gradual increase in arrhythmia recurrences during 12 months after catheter ablation (CA) of atrial fibrillation (AF) is still reported.1

article thumbnail

PO-04-014 DEFYING ABLATION: PERSISTENT ATRIAL FIBRILLATION IN UNTREATED THYROTOXICOSIS

HeartRhythm

Atrial fibrillation (AF) is among the most prevalent arrhythmias. Catheter ablation has demonstrated greater efficacy than antiarrhythmic medications in preventing AF recurrence. Additionally, undiagnosed thyrotoxicosis is identified as a significant risk factor for the failure of recurrent AF ablation.

40
article thumbnail

Asthma is Associated with Higher Recurrence Rates of Atrial Fibrillation Following Catheter Ablation

HeartRhythm

Asthma is a known risk factor for atrial fibrillation (AF), the most common sustained arrhythmia. While radiofrequency catheter ablation is effective in treating AF, the impact of asthma and its severity on ablation outcomes has not been previously explored.

article thumbnail

PO-01-156 UNVEILING CLINICAL AND IMAGING PREDICTORS OF VENTRICULAR TACHYCARDIA ABLATION OUTCOMES IN STRUCTURAL HEART DISEASE PATIENTS: INSIGHTS FROM MULTIVARIATE ANALYSIS OF 508 PROCEDURES

HeartRhythm

Multiple risk factors for arrhythmia recurrence after Ventricular Tachycardia (VT) ablation have been identified. However, the cumulative impact of these risk factors has not been evaluated, making it challenging to predict these risks in patients with multiple coexisting conditions.

article thumbnail

2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Circulation

Additional relevant studies, published through November 2022, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate.StructureAtrial fibrillation is the most sustained common arrhythmia, and its incidence and prevalence are increasing in the United States and globally.

article thumbnail

Catheter ablation approach and outcome in HIV+ patients with recurrent atrial fibrillation

Journal of Cardiovascular Electrophysiology

We present the long-term outcome of catheter ablation (CA) and electrophysiological characteristics in HIV+ AF patients. A total of 31 HIV patients and 31 controls were generated by propensity matching, based on calculated risk factor scores, using a logistic model. vs. 54%, p  < .001], vs. 45.2%, p  < .001]